NCT06104852 Triage Survey for Neurology Research Eligibility
| NCT ID | NCT06104852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adams Clinical |
| Condition | Alzheimer Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-06-02 |
| Primary Completion | 2027-06-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2023-06-02 with a primary completion date of 2027-06-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.
Eligibility Criteria
Inclusion Criteria: * Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed. * Participant and study partner (when applicable) are at least 18 years old. Exclusion Criteria: * Participant lacks the language skills or cognitive ability to understand the screening process. * Participant is pregnant, breast-feeding, or planning to become pregnant. * History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results. * Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening. * Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant. * Any condition that in the investigator's opinion makes a participant unsuitable for the study. * Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06104852 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06104852 currently recruiting?
Yes, NCT06104852 is actively recruiting participants. Contact the research team at sstarling@adamsclinical.com for enrollment information.
Where is the NCT06104852 trial being conducted?
This trial is being conducted at Boston, United States, Watertown, United States, New York, United States.
Who is sponsoring the NCT06104852 clinical trial?
NCT06104852 is sponsored by Adams Clinical. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.